Shinpoong Pharm launches paclitaxel injection

Shinpoong Pharm said recently that after completion of bioequivalence tests in last May, it launched paclitaxel injection (tradename: Padexol), an antineoplastic agent, which is indicated for treatment of breast cancer, ovarian cancer and lung cancer

According to Shinpoong, Padexol is a 100 percent pure extract from yew trees and unlike other paclitaxel preparations, the drug has been prepar...